UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 		OMB APPROVAL
OMB Number 3235-0101
Expires: June 30, 2020
Estimated average burden hours
per response 1.00
FORM 144  
SEC USE ONLY
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 		DOCUMENT SEQUENCE NO.
 
 

ATTENTION:  Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker.

CUSIP NUMBER
 
 
                                    WORK LOCATION
  1(a) NAME OF ISSUER     (b) IRS IDENT. NO.     (c) S.E.C. FILE NO.      
 

Hancock Jaffe Laboratories, Inc.

    33-0936180     001-38325        
 
 

1(d) ADDRESS OF ISSUER

    STREET
    CITY     STATE     ZIP CODE     (e) TELEPHONE NO.  
  70 Doppler, Irvine, California 92618       AREA CODE NUMBER  
 

 

                                (949)     261-2900  
 
                                             
  2(a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD           (b) RELATIONSHIP
TO ISSUER 		    (c) ADDRESS (Street)     CITY     STATE     ZIP CODE  
  Biodyne Holding, S.A (Yury Zhivilo)           Affiliate     13 Rue De La Gare 1100 Morges, 1110, Switzerland                        
 

 

                                         
 

INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.

                                                           
 
              SEC USE                                
  3(a)     (b)     ONLY     (c)     (d)     (e)     (f)     (g)  

 

Title of the
Class of
Securities
To Be Sold 		    Name and Address of Each Broker
Through Whom the Securities are
to be Offered or Each Market Maker
who is Acquiring the Securities 		    Broker-Dealer
File Number 		    Number of
Shares or Other
Units To Be Sold
(See instr. 3(c)) 		    Aggregate
Market Value
(See instr. 3(d)) 		    Number of Shares
or Other Units
Outstanding
(See instr. 3(e)) 		    Approximate
Date of Sale
(See instr. 3(f))
(MO. DAY YR.) 		    Name of Each
Securities
Exchange
(See instr. 3(g)) 		 
 

Common Stock

   

Alexander Capital L.P.

17 State Street

New York, NY 10004

           

300,000 pursuant to a 10b5-1 plan

       

$96,000

(as of 08/06/2020)

 

       

38,324,333

     

08/07/2020

   

The Nasdaq Capital Market

 
                                                           
 
INSTRUCTIONS:
 
 
1. (a) Name of issuer
         
 
(b) Issuer’s I.R.S. Identification Number
         
 
(c) Issuer’s S.E.C. file number, if any
         
 
(d) Issuer’s address, including zip code
         
 
(e) Issuer’s telephone number, including area code
 
 
2. (a) Name of person for whose account the securities are to be sold
         
 
(b) Such person’s relationship to the issuer (e.g., officer, director, 10 percent stockholder, or member of immediate family of any of the foregoing)
         
 
(c) Such person’s address, including zip code
 
3. (a) Title of the class of securities to be sold
         
 
(b) Name and address of each broker through whom the securities are intended to be sold
         
 
(c) Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
         
 
(d) Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
         
 
(e) Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer
         
 
(f) Approximate date on which the securities are to be sold
         
 
(g) Name of each securities exchange, if any, on which the securities are intended to be sold
         
 

Potential persons who are to respond to the collection of information contained in this form are not required
to respond unless the form displays a currently valid OMB control number.

 
 

TABLE I — SECURITIES TO BE SOLD

Furnish the following information with respect to the acquisition of the securities to be sold
and with respect to the payment of all or any part of the purchase price or other consideration therefor:

Title of
the Class 		    Date you
Acquired 		    Name of Acquisition Transaction     Name of Person From
Whom Acquired
(If gift, also give date donor acquired) 		    Amount of
Securities Acquired 		    Date of Payment     Nature of Payment
Common Stock    

May 9, 2006

   

Acquired pursuant to a stock purchase agreement

   

Warren D. Hancock Trust, UTD May 3, 1991, David M. Snow, Trustee

   

4,443,569

    May 9, 2006    

Cash wire transfer

 
INSTRUCTIONS:  

If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

 
 

TABLE II — SECURITIES SOLD DURING THE PAST 3 MONTHS

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

Name and Address of the Seller     Title of Securities Sold     Date of Sale     Amount of
Securities Sold 		    Gross Proceeds

Biodyne Holding, S.A (Yury Zhivilo)

 

13 Rue De La Gare 1100 Morges, 1110, Switzerland

    Common Stock    

From May 7, 2020 through

August 7, 2020

    1,875,583

shares

   

$749,339.31

 

Remarks:

 

 

 

 

INSTRUCTIONS:

See the definition of “person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

August 7, 2020
 
Date of Notice

 

May 28, 2019
 
Date of Plan Adoption or Giving of Instruction,
if Relying on Rule 10b5-1.

 

/s/ Yury Zhivilo

 
(Signature)

The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed.
Any copies not manually signed shall bear typed or printed signatures.

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Hancock Jaffe Laboratories (NASDAQ:HJLI)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Hancock Jaffe Laboratories
Grafico Azioni Hancock Jaffe Laboratories (NASDAQ:HJLI)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Hancock Jaffe Laboratories